Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M100,608Revenue $M36,771Net Margin (%)11.6Altman Z-Score--
Enterprise Value $M111,435EPS $2.0Operating Margin %15.7Piotroski F-Score--
P/E(ttm)16.9Beneish M-Score--Pre-tax Margin (%)14.7Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %2.3Quick Ratio--Cash flow > EarningsN
Price/Sales2.45-y EBITDA Growth Rate %-3.3Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow36.0y-y EBITDA Growth Rate %36.1ROA % (ttm)7.2Higher Current Ratio y-yN
Dividend Yield %4.2PEG--ROE % (ttm)12.6Less Shares Outstanding y-yN
Payout Ratio %72.0Shares Outstanding M2,622ROIC % (ttm)12.8Gross Margin Increase y-yN

Gurus Latest Trades with SNY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYCharles Brandes 2015-12-31 Reduce-0.06%$41.51 - $51.49
($45.91)
$ 38.37-16%Reduce -3.98%2,198,827
SNYJames Barrow 2015-12-31 Add0.02%$41.51 - $51.49
($45.91)
$ 38.37-16%Add 1.26%29,489,368
SNYKen Fisher 2015-12-31 Add0.01%$41.51 - $51.49
($45.98)
$ 38.37-17%Add 0.90%13,416,220
SNYHOTCHKIS & WILEY 2015-09-30 Reduce-0.29%$46.64 - $54.98
($50.92)
$ 38.37-25%Reduce -15.57%9,035,695
SNYCharles Brandes 2015-09-30 Reduce-0.17%$46.64 - $54.98
($50.92)
$ 38.37-25%Reduce -10.56%2,290,031
SNYNWQ Managers 2015-09-30 Reduce-0.09%$46.64 - $54.98
($50.92)
$ 38.37-25%Reduce -5.10%2,501,826
SNYJames Barrow 2015-09-30 Reduce-0.06%$46.64 - $54.98
($50.92)
$ 38.37-25%Reduce -2.80%29,123,564
SNYKen Fisher 2015-09-30 Add0.01%$46.64 - $54.98
($50.92)
$ 38.37-25%Add 0.37%13,295,966
SNYDodge & Cox 2015-09-30 Add$46.64 - $54.98
($50.92)
$ 38.37-25%Add 0.19%49,859,813
SNYNWQ Managers 2015-06-30 Reduce-0.8%$48.81 - $52.35
($50.66)
$ 38.37-24%Reduce -32.87%2,636,361
SNYDodge & Cox 2015-06-30 Add0.3%$48.81 - $52.35
($50.66)
$ 38.37-24%Add 15.64%49,765,693
SNYHOTCHKIS & WILEY 2015-06-30 Reduce-0.19%$48.81 - $52.35
($50.66)
$ 38.37-24%Reduce -9.17%10,701,542
SNYKen Fisher 2015-06-30 Add0.02%$48.81 - $52.35
($50.66)
$ 38.37-24%Add 1.44%13,246,593
SNYJames Barrow 2015-06-30 Reduce-0.02%$48.81 - $52.35
($50.66)
$ 38.37-24%Reduce -0.87%29,961,207
SNYCharles Brandes 2015-06-30 Reduce-0.01%$48.81 - $52.35
($50.66)
$ 38.37-24%Reduce -0.52%2,560,460
SNYNWQ Managers 2015-03-31 Add0.61%$44 - $51.12
($47.81)
$ 38.37-20%Add 33.50%3,927,517
SNYJames Barrow 2015-03-31 Reduce-0.04%$44 - $51.12
($47.81)
$ 38.37-20%Reduce -1.88%30,225,221
SNYHOTCHKIS & WILEY 2015-03-31 Add0.02%$44 - $51.12
($47.81)
$ 38.37-20%Add 0.77%11,782,180
SNYThird Avenue Management 2015-03-31 Sold Out -0.012%$44 - $51.12
($47.81)
$ 38.37-20%Sold Out0
SNYDodge & Cox 2015-03-31 Reduce-0.01%$44 - $51.12
($47.81)
$ 38.37-20%Reduce -0.55%43,034,073
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2015-01-29Buy97,118$95-59.61view
Sanofi10% Owner 2015-01-26Buy647,448$95-59.61view
Sanofi10% Owner 2015-01-22Buy196,251$93.17-58.82view
Sanofi10% Owner 2014-03-25Buy344,448$66.88-42.63view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67400.26view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Dodge & Cox Global Stock Fund 4th Quarter Commentary Jan 19 2016 
    Dodge & Cox Stock Fund 2015 Commentary Jan 18 2016 
    Why MannKind Could Be a Value Trap Jan 04 2016 
    Francis Chou's Holdings Trading at Low PE Dec 23 2015 
    Warren Buffett Further Pares Munich Re Stake Dec 14 2015 
    Weekly 3-Year Low Highlights: Sanofi, Exelon, Cummins, W.W. Grainger Nov 18 2015 
    Why Warren Buffett Sold Munich Re Oct 06 2015 
    MS Global Franchise Fund Reduces Positions in Sanofi, Diageo Sep 16 2015 
    Third Avenue International Value Fund Part 2 Sep 10 2015 
    Dodge & Cox Funds' 2015 Equity Mid-Year Review Aug 19 2015 

    More From Other Websites
    Sanofi -- Moody's: Europe's pharma companies' earnings growth looking less rosy in 2016 Feb 10 2016
    Sanofi Tops Q4 Earnings, Revenues Fall Y/Y, Gives 2016 View Feb 10 2016
    [$$] How a Sanofi Diabetes Bet Went Wrong Feb 10 2016
    Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch Feb 09 2016
    [$$] Sanofi Is Forced to End Latest Diabetes Effort Feb 09 2016
    Sanofi gets shot in the arm from dollar strength Feb 09 2016
    [$$] Sanofi upbeat on prospects for heart drug despite slow start in US Feb 09 2016
    Regeneron: Get Used to Disappointment Feb 09 2016
    Sanofi reports flat 2015 earnings Feb 09 2016
    Sanofi reports flat 2015 earnings Feb 09 2016
    Sanofi's Stock Dips Lower Following Q4 Print Feb 09 2016
    Sanofi Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at Constant Exchange Rates... Feb 09 2016
    [$$] Regeneron Reports Slowing Sales Growth for Key Eye Drug Feb 09 2016
    ​Sanofi Genzyme revenues grow 20% in 2015 to top $4B Feb 09 2016
    Sanofi gets shot in the arm from dollar strength Feb 09 2016
    Sanofi pledges stable 2016 earnings Feb 09 2016
    4:19 am Sanofi beats by EUR0.07; misses on revs; sees 2016 EPS roughly in-line with expectations Feb 09 2016
    [$$] Sanofi Profit Hit By Falling Diabetes Revenue Feb 09 2016
    Sanofi - Full Year 2015 Results Feb 09 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK